Posts

Showing posts with the label Erythromelalgia market forecast

Erythromelalgia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Erythromelalgia, a rare clinical syndrome, manifests with a triad of symptoms: redness, warmth, and burning pain, primarily affecting the extremities. Predominantly, it targets the lower extremities, notably the feet, while in some instances, it can involve the upper extremities, specifically the hands. Drenth and Michiels differentiated between erythromelalgia and erythermalgia based on their responsiveness to aspirin, resulting in three established categories: Erythromelalgia in thrombocythemia, which is platelet-mediated and responds to aspirin. This occurs in conjunction with essential thrombocytosis and polycythemia vera. Primary erythermalgia is an idiopathic or inherited disorder known as aspirin-resistant erythermalgia of unknown origin. Secondary erythermalgia, aspirin-resistant, and linked to various medical conditions. Erythromelalgia in thrombocythemia is associated with essential thrombocytosis and polycythemia vera. Primary erythromela...

Erythromelalgia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
 Erythromelalgia, a rare clinical syndrome, manifests with a triad of symptoms: redness, warmth, and burning pain, primarily affecting the extremities. Predominantly, it targets the lower extremities, notably the feet, while in some instances, it can involve the upper extremities, specifically the hands. Drenth and Michiels differentiated between erythromelalgia and erythermalgia based on their responsiveness to aspirin, resulting in three established categories: 1.        Erythromelalgia in thrombocythemia, which is platelet-mediated and responds to aspirin. This occurs in conjunction with essential thrombocytosis and polycythemia vera. 2.        Primary erythermalgia is an idiopathic or inherited disorder known as aspirin-resistant erythermalgia of unknown origin. 3.        Secondary erythermalgia, aspirin-resistant, and linked to various medical conditions. Erythromelalgia in thromb...